Alemtuzumab Therapy for Multiple Sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Neurology (clinical),Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/s13311-012-0159-0.pdf
Reference28 articles.
1. Riechmann L, et al. Reshaping human antibodies for therapy. Nature 1988;332:323-327.
2. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497.
3. Waldmann H, Hale G. CAMPATH: from concept to clinic. Phil Trans Roy Soc Lond B Biol Sci 2005;360:1707-1711.
4. Lockwood CM, et al. Remission induction in Behcet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H. Rheumatology (Oxford) 2003;42:1539-1544.
5. Dick AD, et al. Campath-1H therapy in refractory ocular inflammatory disease. Br J Ophthalmol 2000;84:107-109.
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Doxorubicin as a Drug Repurposing for Disruption of α-Chymotrypsinogen-A Aggregates;The Protein Journal;2024-07-16
2. Optic Neuritis in the New Millennium;TNOA Journal of Ophthalmic Science and Research;2024-04
3. New targets for old drugs;New Horizons in Natural Compound Research;2023
4. Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery;International Journal of Molecular Sciences;2022-07-29
5. Failure of alemtuzumab therapy in three patients with MOG antibody associated disease;BMC Neurology;2022-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3